LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Bacterial Isolates Identified by Colorimetric Cards

By LabMedica International staff writers
Posted on 21 Dec 2010
Image: Colored scanning electron micrograph (SEM) of Staphylococcus aureus bacteria (yellow) on human nasal epithelial cells (photo courtesy Juergen Berger / Science Photo Library).
Image: Colored scanning electron micrograph (SEM) of Staphylococcus aureus bacteria (yellow) on human nasal epithelial cells (photo courtesy Juergen Berger / Science Photo Library).
A rapid and accurate bacterial identification system for Staphylococci species has been validated in a clinical setting.

A procedure that uses colorimetric identification card and automation has been compared with molecular methods to identify bacteria from patient's samples that were isolated and recovered during routine testing.

Scientists from the Medical School at the University of Athens (Greece), isolated 147 clinical isolates: 52 Staphylococcus aureus, 50 Staphylococcus epidermidis, and 45 other coagulase-negative Staphylococci (CoNS). These isolates were recovered from various clinical samples including blood, wound, catheter tips, respiratory, and urine during routine testing, and for the majority of them, their isolation was considered clinically significant. The bacteria were first identified by molecular methodology and then comparatively tested by Vitek 2, colorimetric identification card, and Phoenix using the novel 0.25 McFarland and the standard 0.50 McFarland inoculum protocols.

All S. aureus isolates were accurately identified. Vitek 2 (bioMérieux, Marcy l'Etoile, France) identified correctly all S. epidermidis and 93.3% of the other CoNS, whereas the respective rates were 86% and 82.2% for Phoenix's standard and 92% and 82.2% for the novel protocol. The PMIC/ID-53 panel for Gram-positive cocci and software version V5.10A/V4.23D were used for identification by Phoenix system (Becton Dickinson Diagnostic Systems, Franklin Lane, NJ, USA).

The authors concluded that both systems provide excellent identification of S. aureus, but Vitek 2 recognizes CoNS species more accurately than Phoenix. The 0.25 McFarland protocol does not improve system performance. However, they also note specificity of testing is an important parameter and needs to be determined also. It is imperative that such evaluation studies use reference phenotypic or molecular identification methods for comparison. The study was published online on November 19, 2010 in Diagnostic Microbiology and Infectious Disease.

Related Links:
University of Athens
bioMérieux
Becton Dickinson Diagnostic Systems


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more